The Menopause Blind Spot: Rage, Mood, and What Five Countries Are Getting Right

Jul 26

   Key Takeaways 
  ●  Canada is moving on menopause: a federal Standing Committee study, provincial research, and a national stigma report are all in progress. 
 ●  Not one measures anger or rage as its own variable. Every country reviewed here has the same gap. 
 ●  Five jurisdictions offer five specific, borrowable policy levers: the UK (employment champion + mandatory action plans), the US (state-level speed + clinical training funding), Australia (existing flexible-work law), Ireland (universal free HRT), and Japan (named, paid, gender-inclusive leave). 
 ●  McKinsey Health Institute estimates closing Canada's women's health gap could add $37 billion annually to the economy by 2040 and give every woman seven more healthy days per year. 
 ●  Canada's actual first-mover opening: become the first country to measure and name rage as a standalone menopause symptom in national survey data and clinical pathways. 
  

Key Takeaways
● Canada is moving on menopause: a federal Standing Committee study, provincial research, and a national stigma report are all in progress.
● Not one measures anger or rage as its own variable. Every country reviewed here has the same gap.
● Five jurisdictions offer five specific, borrowable policy levers: the UK (employment champion + mandatory action plans), the US (state-level speed + clinical training funding), Australia (existing flexible-work law), Ireland (universal free HRT), and Japan (named, paid, gender-inclusive leave).
● McKinsey Health Institute estimates closing Canada's women's health gap could add $37 billion annually to the economy by 2040 and give every woman seven more healthy days per year.
● Canada's actual first-mover opening: become the first country to measure and name rage as a standalone menopause symptom in national survey data and clinical pathways.

A recent TIME feature made the case that the public conversation about menopause has been built around the symptoms easiest to name: hot flashes, sleep loss, brain fog. What it left out, the piece argued, is the symptom doing the most day-to-day damage: what clinicians chart as "irritability" and what many patients call rage.

That gap shows up in the Canadian data, and on closer inspection, in the five international jurisdictions Canada is most often compared to. This analysis reviews what each of those jurisdictions is doing, what Canada is doing, and where a genuine first-mover opening remains.

What Does the Canadian Data Actually Show?

   Finding Source 
  95% of Canadian women report menopausal symptoms; 58% did not know anxiety, and 56% did not know depression, were symptoms of menopause Menopause Foundation of Canada, "The Silence and the Stigma" (2022, n=1,023) 
 92% experienced moderate-to-extremely-severe symptoms; 41.2% reported a concurrent mental health condition HER-BC Study, WHRI / BC Women's Health Foundation / Pacific Blue Cross (2024, n=2,000+) 
 56.95% screened above a clinically significant symptom threshold; 37.66% above threshold for depressive symptoms, 24.38% for anxiety Cross-sectional cohort study, British Columbia, ScienceDirect (2026, n=1,850) 
 Women aged 45 to 64 have the highest diagnosed-anxiety rate of any Canadian age-sex group: 6.8% vs. 3.9% for men Statistics Canada, Canadian Community Health Survey 
 Estimated $3.5 billion in annual economic cost tied to unmanaged menopause symptoms in Canada Menopause Foundation of Canada, cited to federal Standing Committee study 
 85% of Canadian women over 45 say menopause is a health condition employers should take seriously Angus Reid poll commissioned by Astellas (2025) 
  

Finding	Source
95% of Canadian women report menopausal symptoms; 58% did not know anxiety, and 56% did not know depression, were symptoms of menopause	Menopause Foundation of Canada, "The Silence and the Stigma" (2022, n=1,023)
92% experienced moderate-to-extremely-severe symptoms; 41.2% reported a concurrent mental health condition	HER-BC Study, WHRI / BC Women's Health Foundation / Pacific Blue Cross (2024, n=2,000+)
56.95% screened above a clinically significant symptom threshold; 37.66% above threshold for depressive symptoms, 24.38% for anxiety	Cross-sectional cohort study, British Columbia, ScienceDirect (2026, n=1,850)
Women aged 45 to 64 have the highest diagnosed-anxiety rate of any Canadian age-sex group: 6.8% vs. 3.9% for men	Statistics Canada, Canadian Community Health Survey
Estimated $3.5 billion in annual economic cost tied to unmanaged menopause symptoms in Canada	Menopause Foundation of Canada, cited to federal Standing Committee study
85% of Canadian women over 45 say menopause is a health condition employers should take seriously	Angus Reid poll commissioned by Astellas (2025)

None of these studies ask about anger or rage as a standalone category. They use "irritability," "mood swings," or "psychosocial symptoms," which range from tearfulness to fury. A UK clinical cohort of 978 women found irritability was the fourth most common symptom overall, reported by 90% of participants, ahead of hot flashes. The true scale in Canada is likely undercounted rather than absent.

The McKinsey Health Institute's October 2025 Canada-specific analysis adds a sharper economic frame: closing the women's health gap could add $37 billion annually to the Canadian economy by 2040 and give every Canadian woman seven more healthy days per year. Ontario and Quebec alone represent over $20 billion of that opportunity. Canada ranks fifth-worst globally for women's health economic gap as a share of GDP, behind Australia, France, Germany, and Japan, despite ranking among the top ten countries for gender equality overall.

The workforce and economic dimensions of this gap, including what unmanaged menopause symptoms cost Canadian organizations specifically, are explored further in our piece on why women's health in midlife matters as a workforce issue.

How Does Menopause Affect the Brain, and Why Does That Matter for Policy?

Before comparing jurisdictions, it helps to understand what is actually being under-measured. The cognitive symptoms of menopause are better documented than the mood symptoms, but both share the same hormonal root.

Research cited in TIME's October 2025 feature on menopause and brain health found that up to 60% of menopausal women experience brain fog, driven by the effects of fluctuating and declining estrogen and progesterone on the hippocampus and prefrontal cortex. Estrogen also regulates the neurotransmitter systems involved in mood, attention, and emotional stability. When those levels drop, women face elevated risk of depression, anxiety, and what research increasingly describes as "anger" and "feeling out of control," even when studies rarely ask about those experiences directly.

The brain is not passive through this transition. Brain-imaging studies show measurable remodeling and metabolic changes during menopause, with compensatory pathways developing over time. That adaptability is real, but it does not eliminate the cost of the transition, which shows up in work, in relationships, and in the clinical encounter where symptoms are most likely to be mislabelled or missed.

What Are Five Leading Jurisdictions Doing, and What Can Canada Borrow?

United Kingdom: Employment Law and a Named Champion

The Employment Rights Act 2025 is the first UK legislation to explicitly frame menopause as a workplace equality issue. From April 2026, large employers with 250 or more staff are encouraged to voluntarily publish menopause and gender pay gap action plans, with mandatory reporting expected by 2027. Since 2023, a government-appointed Menopause Employment Champion has published national guidance, a progress report, and convened employer roundtables with organizations including Tesco, British Airways, and Rolls-Royce.

Even so, only 24% of women aged 40 to 60 say their employer has a menopause policy, and 1 in 6 have considered leaving work over lack of support. Legislation and a named champion role move the conversation. They do not close the gap alone.

What Canada could borrow: a named accountability role paired with published, mandatory employer action plans, built on infrastructure Canada already uses for pay-equity reporting.

United States: State Laboratories, Federal Funding, and a Measurement Breakthrough

There is no federal menopause law in the US, but state activity is accelerating fast: at least 16 menopause-related bills were introduced across US states in 2026 alone, up from three in 2025. Illinois and Louisiana now mandate insurance coverage for menopause treatment. Rhode Island became the first state to mandate workplace accommodations for menopause, effective June 2025, explicitly naming vasomotor symptoms as a covered condition. A federal bill, H.R. 9090, would direct $25 million per year to NIH for menopause research. In June 2026, Melinda French Gates committed $215 million through Pivotal to embed menopause training directly into ob-gyn residency, primary care, and nursing curricula.

Most notably for this analysis: a 2025 Menopause Society-published study, the Seattle Midlife Women's Health Study, is one of the only studies anywhere to measure anger, irritability, and "feeling out of control" as distinct outcomes across reproductive stages rather than folding them into a general mood score. That is a research design Canada could adopt directly.

What Canada could borrow: fast provincial pilots rather than waiting on one national law, the funder-clinical-society partnership model to fix training gaps, and the Seattle study's measurement approach.

Australia: National Guidelines and Existing Legal Machinery

A Senate inquiry reported in September 2024 with 25 recommendations, 16 of which the federal government supported in principle by February 2025. Rather than legislate a new category, the committee recommended that menopause qualify as a reason to request flexible work under the existing Fair Work Act 2009, reusing legal machinery Australia already had. Backed by a $792.9 million Women's Health Package, Australia introduced Medicare rebates for menopause assessments and opened tender for the country's first national clinical guidelines on perimenopause and menopause in October 2025.

What Canada could borrow: attaching menopause explicitly to existing flexible-work provisions in the Canada Labour Code instead of drafting an entirely new legal category.

Ireland: Universal Access as the Lever

Ireland's HSE launched a national free HRT scheme in June 2025, eliminating the cost of approved HRT medications and dispensing fees for anyone registered for the Drug Payment Scheme or holding a medical card. This sits alongside six national specialist menopause clinics and a public awareness campaign. The model directly targets the kind of gap the BC cohort study found in Canada, where respondents paid an average of roughly $900 per year out of pocket for extended mental health and menopause-related care.

What Canada could borrow: a funded, universal HRT-access model paired with specialist clinics, to close the documented out-of-pocket cost gap.

Japan: Named, Paid, Gender-Inclusive Leave

In October 2023, Tottori Prefecture introduced up to five days of paid special leave per year for menopause and andropause symptoms. The model has since been adopted by companies including POLA ORBIS Holdings and Nichirei. Framing the leave around both menopause and andropause is a deliberate stigma-reduction move: it positions hormonal transition as a shared life-stage issue rather than a women-only complaint. National adoption remains early, and many women report it is still difficult to raise symptoms with managers.

What Canada could borrow: a named, paid leave category with gender-inclusive framing as a deliberate stigma-reduction tool.

Five Jurisdictions at a Glance

   Country Signature lever Status What Canada could borrow 
  United Kingdom Government-appointed Employment Champion and mandatory employer action plans from 2027 In force, phasing in under Employment Rights Act 2025 Named champion role plus published, accountable employer action plans 
 United States State-level insurance mandates and workplace accommodation laws, federal research funding bill, philanthropic-clinical partnership Active, 16+ state bills in 2026, H.R. 9090 pending, Gates/Pivotal funding live Fast provincial pilots, embed menopause training into clinical education, measure anger as its own variable 
 Australia Senate inquiry producing national clinical guidelines and Medicare rebates, menopause tied to existing flexible-work law Guidelines in development, $792.9M Women's Health Package funded Link menopause to existing flexible-work provisions instead of drafting new legal categories 
 Ireland Universal free HRT scheme and six national specialist clinics Live since June 2025 A funded access model that eliminates the out-of-pocket cost gap 
 Japan Dedicated paid leave for menopause and andropause symptoms, up to five days per year Piloted by Tottori Prefecture 2023, adopted by POLA ORBIS and Nichirei A named leave category with gender-inclusive framing to reduce stigma 
  

Country	Signature lever	Status	What Canada could borrow
United Kingdom	Government-appointed Employment Champion and mandatory employer action plans from 2027	In force, phasing in under Employment Rights Act 2025	Named champion role plus published, accountable employer action plans
United States	State-level insurance mandates and workplace accommodation laws, federal research funding bill, philanthropic-clinical partnership	Active, 16+ state bills in 2026, H.R. 9090 pending, Gates/Pivotal funding live	Fast provincial pilots, embed menopause training into clinical education, measure anger as its own variable
Australia	Senate inquiry producing national clinical guidelines and Medicare rebates, menopause tied to existing flexible-work law	Guidelines in development, $792.9M Women's Health Package funded	Link menopause to existing flexible-work provisions instead of drafting new legal categories
Ireland	Universal free HRT scheme and six national specialist clinics	Live since June 2025	A funded access model that eliminates the out-of-pocket cost gap
Japan	Dedicated paid leave for menopause and andropause symptoms, up to five days per year	Piloted by Tottori Prefecture 2023, adopted by POLA ORBIS and Nichirei	A named leave category with gender-inclusive framing to reduce stigma

What Gap Do Even the Leaders Share?

Across all five jurisdictions, not one piece of employment law, insurance mandate, or clinical guideline reviewed here names "anger" or "rage" directly. They use "vasomotor symptoms," "psychological symptoms," or "mood." The single exception is the Seattle Midlife Women's Health Study, and it is a research design, not a policy.

That leaves an actual first-mover opening. No country in this comparison has yet built a national survey question, a workplace guidance line, or a clinical pathway that names anger on its own terms. Whoever does it first sets the definition everyone else eventually borrows.

What Are the Specific Opportunities for Canada?

● Borrow the UK model: a named accountability role paired with published, mandatory employer action plans, built on pay-equity reporting infrastructure Canada already uses.

● Borrow the US approach: fast provincial pilots in BC or Ontario rather than waiting on one national law, plus the funder-clinical-society partnership model to fix training gaps in medical school and residency curricula.

● Borrow Australia's approach: attach menopause explicitly to existing flexible-work provisions in the Canada Labour Code instead of drafting a new legal category from scratch.

● Borrow Ireland's approach: a funded, universal HRT-access model paired with specialist clinics, to close the out-of-pocket cost gap Canadian data already documents.

● Borrow Japan's approach: a named, paid leave category with gender-inclusive framing as a deliberate stigma-reduction tool.

● Lead where no one else has: adopt the Seattle Midlife Women's Health Study's measurement approach in Canada's next national survey, so that anger and rage are asked about explicitly rather than folded into "mood."

The Conclusion

No single country has solved this. The UK leads on employment law. The US leads on policy velocity and, in one study, measurement. Australia leads on tying menopause to existing legal machinery. Ireland leads on universal access. Japan leads on naming a dedicated leave category.

Canada's opening is not to copy one of these countries wholesale. It is to borrow the sharpest piece from each, while becoming the first to close the one gap that all five have left open: naming and measuring rage as what it is, rather than folding it into "mood" and moving on.

Frequently Asked Questions

Which countries have the strongest menopause workplace policies?

The UK is currently the furthest along on employment law, with the Employment Rights Act 2025 establishing mandatory employer reporting requirements and a government-appointed Menopause Employment Champion. Rhode Island in the US was the first jurisdiction anywhere to mandate workplace accommodations specifically for menopause symptoms, effective June 2025. Australia is developing the first national clinical guidelines for perimenopause and menopause, backed by a $792.9 million federal women's health package.

Does Canada have a menopause workplace policy?

Not yet at the federal level. A House of Commons Standing Committee began studying the labour-force impacts of menopause and perimenopause in 2026. Provincial action varies. Ontario and BC have the most active research and advocacy ecosystems, and either province could pilot insurance-coverage or workplace-accommodation provisions the way US states have, without waiting on federal legislation.

Why is anger and rage missing from menopause research and policy?

Most clinical screening tools and national surveys use broad categories like "irritability" or "mood symptoms" that conflate tearfulness and fury. There is also a gender bias at play: anger is an emotion women are often taught to suppress or feel ashamed of, which makes it less likely to be disclosed in a clinical setting or captured in self-report surveys. The result is that data on perimenopausal anger is sparse, which makes it easier for policy to overlook. The 2025 Seattle Midlife Women's Health Study is the closest any research has come to measuring anger and irritability as distinct outcomes, but it is a single study, not yet embedded in clinical guidelines or survey methodology anywhere.

What is the economic cost of unmanaged menopause symptoms in Canada?

The Menopause Foundation of Canada estimates $3.5 billion in annual economic cost tied to unmanaged symptoms. The McKinsey Health Institute's 2025 Canada-specific analysis places the broader women's health gap at $37 billion in annual GDP opportunity by 2040, with Ontario and Quebec representing over $20 billion of that figure. Canada ranks fifth-worst globally for the women's health economic gap as a share of projected 2040 GDP.

Sources

Menopause Foundation of Canada. "The Silence and the Stigma: Menopause in Canada." 2022. https://menopausefoundationcanada.ca/menopause-in-canada-report/

HER-BC Study. Women's Health Research Institute / BC Women's Health Foundation / Pacific Blue Cross. 2024. https://www.pac.bluecross.ca/news-articles/british-columbia-s-first-ever-menopause-study-uncovers-critical-challenges-for-midlife-women/

Cross-sectional cohort study of menopause-related symptoms in British Columbia. ScienceDirect. 2026. https://www.sciencedirect.com/science/article/pii/S0378512226000514

Statistics Canada. "Mood disorders among older Canadians." Health Reports. December 2025. https://www150.statcan.gc.ca/n1/pub/82-003-x/2025012/article/00002-eng.htm

"Workplaces need to take menopause seriously, federal committee told." Canadian Affairs. June 2026. https://www.canadianaffairs.news/2026/06/17/workplaces-need-to-take-menopause-seriously-committee-told/

McKinsey Health Institute. "Closing the women's health gap: Canada's $37 billion opportunity." October 2025. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-canadas-37-billion-dollars-opportunity

Higgins, L. "What Menopause Does to the Brain." TIME. October 2025. https://time.com/collections/time-for-you-menopause/7328125/menopause-brain-health/

Ashfords. Changes to menopause in the workplace under the Employment Rights Act 2025 (UK). https://www.ashfords.co.uk/insights/articles/changes-to-menopause-in-the-workplace-under-the-employment-rights-act-2025

GOV.UK. "No Time to Step Back": the Menopause Employment Champion. https://www.gov.uk/government/publications/no-time-to-step-back-the-governments-menopause-employment-champion

Littler. "Rhode Island Becomes First State to Mandate Workplace Accommodations for Menopause." https://www.littler.com/news-analysis/asap/rhode-island-becomes-first-state-mandate-workplace-accommodations-menopause

Axios. "More than half of US states have taken up menopause legislation." 2026. https://www.axios.com/2026/06/11/menopause-legislation-bills-map

Congress.gov. H.R. 9090, Advancing Menopause Care and Mid-Life Women's Health Act. https://www.congress.gov/bill/119th-congress/house-bill/9090/text/ih

TIME. "Melinda French Gates Is Donating $215 Million to Women's Health." 2026. https://time.com/article/2026/06/04/melinda-french-gates-pivotal-womens-health-midlife/

The Menopause Society. Seattle Midlife Women's Health Study. Effects of menstrual cycle phase and reproductive aging stage on arousal symptoms. 2025. https://menopause.org/press-releases/womens-menstrual-cycle-phase-and-reproductive-stage-effect-levels-of-irritability-and-anger

Parliament of Australia. Senate inquiry: Issues related to menopause and perimenopause. https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Menopause

Australian Government Department of Health. National clinical guidelines for perimenopause and menopause milestone. https://www.health.gov.au/ministers/the-hon-rebecca-white-mp/media/milestone-for-australians-first-national-clinical-guidelines-for-perimenopause-and-menopause

Irish Pharmacy News. "Free HRT for Women in Ireland: A Landmark Moment in Menopause Care." https://irishpharmacynews.ie/free-hrt-for-women-in-ireland-a-landmark-moment-in-menopause-care/

World Economic Forum. "Andropause awareness moves us towards a healthier society." Japan. December 2025. https://www.weforum.org/stories/2025/12/andropause-awareness-japan/

BJPsych Open. Prevalence of Cognitive and Mood-Related Symptoms in a Large Cohort of Perimenopausal and Menopausal Women. UK cohort, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11738833/

Note: figures are drawn from publicly available survey summaries, government releases, and secondary press coverage. Where a primary study was paywalled or otherwise inaccessible, figures are cited as reported by the study's official press release or press coverage, as noted above.

perimenopausementalhealthworkplaceragebrainfog

Pam Sethi